HAHN MARK W (Chief Financial Officer) reported 1 transaction at DOVA PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/12/2019ACC: 0001209191-19-056025
Officer· Chief Financial Officer
Since Oct 2018
-309.02K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
309.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.02K
Price / share
—
Trade value
—
% of position
New position
11/12/2019
9.02K→0.00
Total
Net shares
−9.02K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/12/2019 | D · Disposition | −9.02K | — | — | New position | 9.02K | 0.00 |
| Total | −9.02K | $0.00 | ||||||
Derivative Transactions2
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
20.42
Held after
0.00
Exercisable
—
11/12/2019
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
250K shares
Shares
−250K
Strike price
8.82
Held after
0.00
Exercisable
—
11/12/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock50K shares | 11/12/2019 | D · Disposition | −50K | 20.42 | — | 0.00 |
| Employee Stock Option (Right to Buy) Direct | Common Stock250K shares | 11/12/2019 | D · Disposition | −250K | 8.82 | — | 0.00 |